511 filings
Page 18 of 26
424B3
BNKL
Bionik Laboratories Corp.
15 Feb 17
Prospectus supplement
12:00am
424B3
BNKL
Bionik Laboratories Corp.
15 Feb 17
Prospectus supplement
12:00am
8-K
BNKL
Bionik Laboratories Corp.
15 Feb 17
Bionik Laboratories Reports Third Quarter Fiscal Year 2017 Financial Results
12:00am
424B3
BNKL
Bionik Laboratories Corp.
15 Feb 17
Prospectus supplement
12:00am
10-Q
2017 Q3
BNKL
Bionik Laboratories Corp.
Quarterly report
14 Feb 17
12:00am
424B3
BNKL
Bionik Laboratories Corp.
8 Feb 17
Prospectus supplement
12:00am
EFFECT
BNKL
Bionik Laboratories Corp.
3 Feb 17
Notice of effectiveness
12:00am
CORRESP
BNKL
Bionik Laboratories Corp.
2 Feb 17
Correspondence with SEC
12:00am
8-K
BNKL
Bionik Laboratories Corp.
30 Jan 17
Regulation FD Disclosure
12:00am
8-K
BNKL
Bionik Laboratories Corp.
9 Jan 17
Regulation FD Disclosure
12:00am
8-K
BNKL
Bionik Laboratories Corp.
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
EFFECT
BNKL
Bionik Laboratories Corp.
28 Dec 16
Notice of effectiveness
12:00am
S-1/A
BNKL
Bionik Laboratories Corp.
IPO registration (amended)
27 Dec 16
12:00am
CORRESP
BNKL
Bionik Laboratories Corp.
22 Dec 16
Correspondence with SEC
12:00am
424B3
BNKL
Bionik Laboratories Corp.
21 Dec 16
Prospectus supplement
12:00am
8-K
BNKL
Bionik Laboratories Corp.
20 Dec 16
Bionik Laboratories Advances InMotion AnkleBot into Commercial Development
12:00am
EFFECT
BNKL
Bionik Laboratories Corp.
20 Dec 16
Notice of effectiveness
12:00am
POS AM
BNKL
Bionik Laboratories Corp.
13 Dec 16
Prospectus update (post-effective amendment)
12:00am
S-1/A
BNKL
Bionik Laboratories Corp.
IPO registration (amended)
18 Nov 16
12:00am
8-K
BNKL
Bionik Laboratories Corp.
15 Nov 16
Bionik Laboratories Reports Second Quarter Fiscal Year 2017 Financial Results
12:00am